Denali Therapeutics Inc
- Stock Issuer and Owners
Denali Therapeutics Inc |
Ticker | DNLI |
CIK # | 0001714899 |
CUSIP | 24823R105 |
Sector | Life Sciences - Biological Products, (No Disgnostic Substances) |
Address | 151 Oyster Point Blvd 2Nd Floor, South San Francisco, CA 94080 |
Source |
[EDGAR]
|
Form 13F Holdings |
Firm |
Period |
DFND |
Voting |
Shares |
Vanguard Group Inc |
[2023-03-31]
|
SOLE |
0.0 |
9,830,055.0 |
BlackRock Inc. |
[2023-03-31]
|
SOLE |
9,228,805.0 |
9,473,812.0 |
Baillie Gifford & Co |
[2023-03-31]
|
DFND |
7,985,895.0 |
8,159,452.0 |
Baillie Gifford & Co |
[2023-03-31]
|
SOLE |
7,192,659.0 |
7,192,659.0 |
Temasek Holdings (Private) Ltd |
[2023-03-31]
|
DFND |
6,895,992.0 |
6,895,992.0 |
Crestline Management LP |
[2023-03-31]
|
SOLE |
6,410,732.0 |
6,410,732.0 |
Wellington Management Group LLP |
[2023-03-31]
|
DFND |
0.0 |
5,200,460.0 |
State Street Corp |
[2023-03-31]
|
DFND |
4,361,446.0 |
4,591,389.0 |
Price T Rowe Associates Inc /MD/ |
[2023-03-31]
|
SOLE |
593,519.0 |
3,453,799.0 |
Flagship Pioneering Inc |
[2023-03-31]
|
DFND |
0.0 |
2,619,968.0 |
Arch Venture Management LLC |
[2023-03-31]
|
SOLE |
0.0 |
2,568,749.0 |
Capital Research Global Investors |
[2023-03-31]
|
DFND |
2,468,824.0 |
2,468,824.0 |
Geode Capital Management LLC |
[2023-03-31]
|
DFND |
2,146,172.0 |
2,146,172.0 |
Bank of New York Mellon Corp |
[2023-03-31]
|
DFND |
1,753,848.0 |
1,918,129.0 |
Gilder Gagnon Howe & Co LLC |
[2023-03-31]
|
DFND |
0.0 |
1,656,397.0 |
Credit Suisse AG |
[2023-03-31]
|
DFND |
1,498,313.0 |
1,553,472.0 |
Citadel Advisors LLC |
[2023-03-31]
|
DFND |
1,408,725.0 |
1,408,725.0 |
Casdin Capital LLC |
[2023-03-31]
|
SOLE |
1,300,000.0 |
1,300,000.0 |
Pictet Asset Management Sa |
[2023-03-31]
|
DFND |
1.0 |
1,248,490.0 |
FMR LLC |
[2023-03-31]
|
DFND |
1,090,523.0 |
1,093,564.0 |
Baker Bros Advisors LP |
[2023-03-31]
|
SOLE |
1,088,738.0 |
1,088,738.0 |
Federated Hermes Inc |
[2023-03-31]
|
DFND |
1,063,500.0 |
1,063,500.0 |
Northern Trust Corp |
[2023-03-31]
|
DFND |
62,322.0 |
1,017,812.0 |
Yiheng Capital Management LP |
[2023-03-31]
|
SOLE |
1,014,684.0 |
1,014,684.0 |
Charles Schwab Investment Management Inc |
[2023-03-31]
|
SOLE |
836,328.0 |
836,328.0 |
Artal Group S.A. |
[2023-03-31]
|
DFND |
802,899.0 |
802,899.0 |
Barclays PLC |
[2023-03-31]
|
SOLE |
656,427.0 |
656,427.0 |
T. Rowe Price Investment Management, Inc. |
[2023-03-31]
|
SOLE |
207,175.0 |
647,013.0 |
Cercano Management LLC |
[2023-03-31]
|
SOLE |
625,000.0 |
625,000.0 |
Deerfield Management Company LP Series C |
[2023-03-31]
|
DFND |
594,989.0 |
594,989.0 |
Prev | Page 1 | Next
|
{"search": "/search", "clicked": "/clicked", "portfolio_add": "/portfolio-add", "portfolio_remove": "/portfolio-remove", "portfolio_create": "/portfolio-create", "portfolio_activate": "/portfolio-activate", "portfolio_delete": "/portfolio-delete", "portfolio_rename": "/portfolio-rename", "portfolio_color": "/portfolio-color", "home_filter": "/home-filter", "htmlspeed": "/htmlspeed", "add_tag_firm": "/add-tag-firm", "add_tag_click": "/add-tag-click", "copy_aum": "/copy-aum", "stripe_checkout": "/stripe-checkout", "update_card": "/update-card"}
{"uid": 120469665, "pid": -1, "pid_a": [], "name": "", "email": "", "blacklist_f": false, "paywall_f": false, "paywall_n": 0, "random_n": 0}
False
163496854